258 related articles for article (PubMed ID: 25548216)
21. Broad-spectrum antibodies against self-antigens and cytokines in RAG deficiency.
Walter JE; Rosen LB; Csomos K; Rosenberg JM; Mathew D; Keszei M; Ujhazi B; Chen K; Lee YN; Tirosh I; Dobbs K; Al-Herz W; Cowan MJ; Puck J; Bleesing JJ; Grimley MS; Malech H; De Ravin SS; Gennery AR; Abraham RS; Joshi AY; Boyce TG; Butte MJ; Nadeau KC; Balboni I; Sullivan KE; Akhter J; Adeli M; El-Feky RA; El-Ghoneimy DH; Dbaibo G; Wakim R; Azzari C; Palma P; Cancrini C; Capuder K; Condino-Neto A; Costa-Carvalho BT; Oliveira JB; Roifman C; Buchbinder D; Kumanovics A; Franco JL; Niehues T; Schuetz C; Kuijpers T; Yee C; Chou J; Masaad MJ; Geha R; Uzel G; Gelman R; Holland SM; Recher M; Utz PJ; Browne SK; Notarangelo LD
J Clin Invest; 2015 Nov; 125(11):4135-48. PubMed ID: 26457731
[TBL] [Abstract][Full Text] [Related]
22. Protective targeting of high mobility group box chromosomal protein 1 in a spontaneous arthritis model.
Ostberg T; Kawane K; Nagata S; Yang H; Chavan S; Klevenvall L; Bianchi ME; Harris HE; Andersson U; Palmblad K
Arthritis Rheum; 2010 Oct; 62(10):2963-72. PubMed ID: 20533288
[TBL] [Abstract][Full Text] [Related]
23. Innate immunity and arthritis: neutrophil Rac and toll-like receptor 4 expression define outcomes in infection-triggered arthritis.
Zhang X; Glogauer M; Zhu F; Kim TH; Chiu B; Inman RD
Arthritis Rheum; 2005 Apr; 52(4):1297-304. PubMed ID: 15818670
[TBL] [Abstract][Full Text] [Related]
24. Essential role of high-mobility group box proteins in nucleic acid-mediated innate immune responses.
Yanai H; Ban T; Taniguchi T
J Intern Med; 2011 Oct; 270(4):301-8. PubMed ID: 21793952
[TBL] [Abstract][Full Text] [Related]
25. Destructive role of myeloid differentiation factor 88 and protective role of TRIF in interleukin-17-dependent arthritis in mice.
Abdollahi-Roodsaz S; van de Loo FA; Koenders MI; Helsen MM; Walgreen B; van den Bersselaar LA; Arntz OJ; Takahashi N; Joosten LA; van den Berg WB
Arthritis Rheum; 2012 Jun; 64(6):1838-47. PubMed ID: 22147588
[TBL] [Abstract][Full Text] [Related]
26. Development of TLR inhibitors for the treatment of autoimmune diseases.
Barrat FJ; Coffman RL
Immunol Rev; 2008 Jun; 223():271-83. PubMed ID: 18613842
[TBL] [Abstract][Full Text] [Related]
27. Controlling systems of nucleic acid sensing-TLRs restrict homeostatic inflammation.
Fukui R; Miyake K
Exp Cell Res; 2012 Aug; 318(13):1461-6. PubMed ID: 22507273
[TBL] [Abstract][Full Text] [Related]
28. Cytosolic Nucleic Acid Sensors in Inflammatory and Autoimmune Disorders.
Khan S; Godfrey V; Zaki MH
Int Rev Cell Mol Biol; 2019; 344():215-253. PubMed ID: 30798989
[TBL] [Abstract][Full Text] [Related]
29. Cytokine-dependent but acquired immunity-independent arthritis caused by DNA escaped from degradation.
Kawane K; Tanaka H; Kitahara Y; Shimaoka S; Nagata S
Proc Natl Acad Sci U S A; 2010 Nov; 107(45):19432-7. PubMed ID: 20974942
[TBL] [Abstract][Full Text] [Related]
30. Suppression of systemic autoimmunity by the innate immune adaptor STING.
Sharma S; Campbell AM; Chan J; Schattgen SA; Orlowski GM; Nayar R; Huyler AH; Nündel K; Mohan C; Berg LJ; Shlomchik MJ; Marshak-Rothstein A; Fitzgerald KA
Proc Natl Acad Sci U S A; 2015 Feb; 112(7):E710-7. PubMed ID: 25646421
[TBL] [Abstract][Full Text] [Related]
31. Cell-intrinsic expression of TLR9 in autoreactive B cells constrains BCR/TLR7-dependent responses.
Nündel K; Green NM; Shaffer AL; Moody KL; Busto P; Eilat D; Miyake K; Oropallo MA; Cancro MP; Marshak-Rothstein A
J Immunol; 2015 Mar; 194(6):2504-12. PubMed ID: 25681333
[TBL] [Abstract][Full Text] [Related]
32. Genetic control of antibody production during collagen-induced arthritis development in heterogeneous stock mice.
Förster M; Raposo B; Ekman D; Klaczkowska D; Popovic M; Nandakumar KS; Lindvall T; Hultqvist M; Teneva I; Johannesson M; Ahlqvist E; Holmdahl R
Arthritis Rheum; 2012 Nov; 64(11):3594-603. PubMed ID: 22886420
[TBL] [Abstract][Full Text] [Related]
33. AIM2 inflammasome is dispensable for the host defense against Pseudomonas aeruginosa infection.
Pang Z; Sun G; Junkins RD; Lin TJ
Cell Mol Biol (Noisy-le-grand); 2015 Jun; 61(3):63-70. PubMed ID: 26107502
[TBL] [Abstract][Full Text] [Related]
34. Toll-like receptor-independent gene induction program activated by mammalian DNA escaped from apoptotic DNA degradation.
Okabe Y; Kawane K; Akira S; Taniguchi T; Nagata S
J Exp Med; 2005 Nov; 202(10):1333-9. PubMed ID: 16301743
[TBL] [Abstract][Full Text] [Related]
35. Activation of cannabinoid receptor 2 attenuates synovitis and joint distruction in collagen-induced arthritis.
Gui H; Liu X; Liu LR; Su DF; Dai SM
Immunobiology; 2015 Jun; 220(6):817-22. PubMed ID: 25601571
[TBL] [Abstract][Full Text] [Related]
36. Toll-like receptor 2 controls acute immune complex-driven arthritis in mice by regulating the inhibitory Fcγ receptor IIB.
Abdollahi-Roodsaz S; Koenders MI; Walgreen B; Bolscher J; Helsen MM; van den Bersselaar LA; van Lent PL; van de Loo FA; van den Berg WB
Arthritis Rheum; 2013 Oct; 65(10):2583-93. PubMed ID: 23860661
[TBL] [Abstract][Full Text] [Related]
37. Ameliorated course of glucose-6-phosphate isomerase (G6PI)-induced arthritis in IFN-γ receptor knockout mice exposes an arthritis-promoting role of IFN-γ.
Frey O; Mitera T; Kelchtermans H; Schurgers E; Kamradt T; Matthys P
J Autoimmun; 2011 Mar; 36(2):161-9. PubMed ID: 21262564
[TBL] [Abstract][Full Text] [Related]
38. Complement receptor CR2/CR1 deficiency protects mice from collagen-induced arthritis and associates with reduced autoantibodies to type II collagen and citrullinated antigens.
Kuhn KA; Cozine CL; Tomooka B; Robinson WH; Holers VM
Mol Immunol; 2008 May; 45(10):2808-19. PubMed ID: 18374982
[TBL] [Abstract][Full Text] [Related]
39. Absence of Fms-like tyrosine kinase 3 ligand (Flt3L) signalling protects against collagen-induced arthritis.
Ramos MI; Karpus ON; Broekstra P; Aarrass S; Jacobsen SE; Tak PP; Lebre MC
Ann Rheum Dis; 2015 Jan; 74(1):211-9. PubMed ID: 24064002
[TBL] [Abstract][Full Text] [Related]
40. Cutting edge: TLR13 is a receptor for bacterial RNA.
Hidmark A; von Saint Paul A; Dalpke AH
J Immunol; 2012 Sep; 189(6):2717-21. PubMed ID: 22896636
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
